The sensitivity of the CD133+CD44+CD26+ cellular subpopulation was higher than serum CEA in both diagnosis of CRC and early-stage CRC (70.4% vs. 50.0% and 61.1% vs. 27.8%, respectively) (Table 3, Supplementary Figure S2, left panel). The gene discussed is PROM1; the disease is colorectal carcinoma.